Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Daniel Hall-Flavin, M.D., has an interest in addiction psychiatry, and is currently involved in research that seeks to identify factors, including genetic factors, which render an individual susceptible to addiction and susceptible to relapse to use after recovery has been initiated.
His current research efforts involve the genetic basis of altered metabolism of drugs used to treat alcoholism. Dr. Hall-Flavin is also interested in working with the Departmental Genomics study group in establishing a genomics database in addiction psychiatry.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.